These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7316505)

  • 21. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.
    Weinberger KM; Bauer T; Böhm S; Jilg W
    J Gen Virol; 2000 May; 81(Pt 5):1165-74. PubMed ID: 10769057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
    Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
    J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection.
    Kong D; Wu D; Wang T; Li T; Xu S; Chen F; Jin X; Lou G
    Int J Infect Dis; 2013 Jul; 17(7):e535-8. PubMed ID: 23474175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tubular forms of hepatitis B surface antigen bind with the nucleus of 22-nm spherical HBsAg particles.
    Mishiro S; Imai M; Gotanda T; Takahashi K; Sano T; Yoshizawa H; Miyakawa Y; Mayumi M
    J Med Virol; 1981; 6(4):269-78. PubMed ID: 7241094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.
    Torresi J; Earnest-Silveira L; Deliyannis G; Edgtton K; Zhuang H; Locarnini SA; Fyfe J; Sozzi T; Jackson DC
    Virology; 2002 Feb; 293(2):305-13. PubMed ID: 11886250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the identification of hepatitis viruses.
    Dienstag JL; Purcell RH
    Postgrad Med J; 1977 Jul; 53(621):364-73. PubMed ID: 196274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.
    Borisova G; Arya B; Dislers A; Borschukova O; Tsibinogin V; Skrastina D; Eldarov MA; Pumpens P; Skryabin KG; Grens E
    J Virol; 1993 Jun; 67(6):3696-701. PubMed ID: 7684473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
    Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
    AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA.
    Dow BC; Peterkin MA; Green RH; Cameron SO
    Vox Sang; 2001; 81(2):140. PubMed ID: 11555478
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells.
    Roingeard P; Lu SL; Sureau C; Freschlin M; Arbeille B; Essex M; Romet-Lemonne JL
    Hepatology; 1990 Feb; 11(2):277-85. PubMed ID: 2407629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.
    Cheng PN; Tsai HW; Chiu YC; Ho CH; Wu IC; Chang TT
    J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture.
    Payan C; Cottin J; Lemarie C; Ramont C
    J Hosp Infect; 2001 Apr; 47(4):282-7. PubMed ID: 11289771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens.
    Tan WS
    J Gen Appl Microbiol; 2002 Apr; 48(2):103-7. PubMed ID: 12469306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal pre-C region.
    Tong SP; Diot C; Gripon P; Li J; Vitvitski L; Trépo C; Guguen-Guillouzo C
    Virology; 1991 Apr; 181(2):733-7. PubMed ID: 2014646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disinfection and surface changes of gutta-percha cones after immersion in sodium hypochlorite solution containing surfactant.
    Vitali FC; Nomura LH; Delai D; Henriques DHN; Alves AMH; da Fonseca Roberti Garcia L; Bortoluzzi EA; Teixeira CS
    Microsc Res Tech; 2019 Aug; 82(8):1290-1296. PubMed ID: 30993775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae.
    Howard CR; Young PR; Lee S; Dixon J; Zuckerman AJ; McAleer WJ; Lehman ED
    J Virol Methods; 1986 Aug; 14(1):25-35. PubMed ID: 2945830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase activity in hepatitis B virus.
    Albin C; Robinson WS
    J Virol; 1980 Apr; 34(1):297-302. PubMed ID: 7373711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.